These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Current status of alpha-fetoprotein testing. Macri JN Clin Lab Med; 1981 Jun; 1(2):181-98. PubMed ID: 6179687 [No Abstract] [Full Text] [Related]
6. In California, voluntary mass prenatal screening. Steinbrook R Hastings Cent Rep; 1986 Oct; 16(5):5-7. PubMed ID: 2429941 [TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening for neural tube defects and Down syndrome. Keith D Clin Lab Sci; 1992; 5(5):274-6. PubMed ID: 10150964 [No Abstract] [Full Text] [Related]
8. Criticism of the California alpha fetoprotein screening program. Lasnover AL West J Med; 1987 Jan; 146(1):100. PubMed ID: 2435065 [No Abstract] [Full Text] [Related]
18. Recurrent false-positives in AFP screening for open neural tube defects. Wald NJ; Huttly WJ; Rudnicka AR Prenat Diagn; 2004 Dec; 24(12):1018-9. PubMed ID: 15614882 [No Abstract] [Full Text] [Related]
19. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)]. Thix J Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823 [TBL] [Abstract][Full Text] [Related]